We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Amgen Inc | TG:AMGN | Tradegate | Bond |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.035 | 0.04% | 97.48 | 97.44 | 97.52 | 0 | 22:50:21 |
From Jul 2019 to Jul 2024
U.K. diagnostics company DxS Ltd. Monday said it has licensed its Scorpions technology to chemicals giant DuPont Co. (DD).
The license was granted to DuPont Qualicon, a unit of DuPont that sells systems used by food companies to screen their products for potentially dangerous bugs. Financial terms weren't disclosed.
DuPont is the latest big company to strike a deal with Manchester, England-based DxS. Biotechnology major Amgen Inc. (AMGN) uses a DxS test to determine whether patients with a certain genetic mutation are likely to respond to its cancer drug Vectibix, while Swiss pharmaceutical company Roche Holding AG (ROG.VX) also has a distribution deal with the firm.
Company Web site: www.dxsdiagnostics.com
-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary. You can use this link on the day this article is published and the following day.
1 Year Amgen Chart |
1 Month Amgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
